Webinar Overview

In this webinar, Oksana A. Kamneva, PharmD, BCPS, RPh, and Lindsay Goolsby, MS, RD, LDN, CDCES, discuss nonpharmacologic therapies for Heart Failure (HF). In particular, they review the importance of dietary management, weight control, diabetes management, and participation in cardiac rehabilitation.

This webinar is part of the Transform HF Care: New Horizons in Treatment initiative, supported by Bayer AG. Visit the Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment online course to access additional educational activities on this topic.

Key Objectives/Learning Outcomes:

1. Evaluate the epidemiology, risk factors, comorbidities, and community aspects associated with HF to determine best practices for care.
2. Distinguish pathophysiologic characteristics when evaluating and diagnosing HF, including current classifications, genotypes, and phenotypes, to analyze best HF risk stratification, prevention, and management strategies.
3. Incorporate GDMT, newer therapies, and interprofessional team strategies into treatment care plans for the management of HF to improve care coordination, communication, and patient outcomes.

Webinar Recording

Webinar Participants

Oksana A. Kamneva, PharmD, BCPS, RPh
Lindsay Goolsby, MS, RD, LDN, CDCES

Credit Information

No credit is being offered for this webinar.